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Abstract During the acute phase response, cytokines induce
hepatic metallothionein and ceruloplasmin synthesis and the
uptake of metals. We have investigated how copper and
cytokines may interact in controlling ceruloplasmin (CP) and
metallothionein mRNA in liver cells. We found that IL-1K, IL-
1L and IL-6 increased both metallothionein-1 (MT-1) and
metallothionein-2 (MT-2) mRNA in HepG2 cells. The time
and pattern of induction was different, both IL-1K and IL-1L
inducing two peaks of MT-1 and MT-2, with that of MT-2 being
much larger. IL-6 induced only low levels of both MT-1 and MT-
2 mRNA. CP mRNA was also increased after 16 h by IL-1L,
whereas IL-1K induced two CP peaks at 8 and 20 h, while IL-6
had little effect. Copper administration gave rise to substantially
increased MT-1 mRNA, a slightly lower increase in MT-2 and
also a significant increase in CP mRNA with similar kinetics.
These parallel increases in MT and CP mRNA suggest that the
coordinated expression of these proteins may be important for
their synthesis during the acute phase response.
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1. Introduction
During the acute phase of an in£ammatory response, a
substantial change occurs in the synthesis by the liver of the
plasma cuproprotein ceruloplasmin (CP). This is a well-de-
scribed acute phase protein which has anti-oxidant properties
and plays an important role in controlling iron release from
cells [1]. The oxidase function of CP is dependent on its multi-
ple copper atoms [2] and yet, the presence of copper is re-
ported not to in£uence the production of the protein by the
liver, since protein synthesis occurs irrespective of the supply
of copper [3,4]. In in£ammation, however, metals accumulate
in the liver, as a result of the increased synthesis of the low
molecular weight metal-binding protein, metallothionein
(MT). Cytokines, predominantly interleukin-1 (IL-1) and in-
terleukin-6 (IL-6), have been shown to be responsible for the
observed changes in liver protein synthesis [5]. The increased
MT synthesis during in£ammation results in an increase in the
intracellular pool of copper available and may so facilitate the
increased synthesis of fully functional holo-CP. While the
functions of MT remain somewhat enigmatic, a role as a
chaperone or reservoir of metals is generally accepted [6].
Cytoplasmic MT-derived copper may be released by reduction
by glutathione, as occurs with zinc [7,8], and then transported
into the Golgi or endoplasmic reticulum by the P-type ATP-
ase copper transporter [9,10] for incorporation into CP. How-
ever, for this to be relevant to the acute phase response, a
coordinated increase in the transcription of MT and CP
would be expected, but there have been few studies investigat-
ing the relationship between the expression of these proteins.
The aim of this study was to examine the kinetics of changes
in MT and CP mRNA in response to in£ammatory cytokines
and copper in vitro, using the human hepatoma cell line
HepG2. We found that both IL-1K, IL-1L and copper up-
regulated mRNA for MT-1, MT-2 and CP while IL-6 had
only a small e¡ect. Their up-regulation followed similar ki-
netics, suggesting that their coordinated control may be im-
portant for optimal control of copper uptake and functional
protein synthesis during the acute phase response.
2. Materials and methods
2.1. DNA probes
A cDNA probe for CP was provided by Dr D. Critchley, Leicester
University, in the form of a lambda gt11 clone derived from a rat liver
phage library. This was re-cloned into the EcoRI restriction sites of
pUC18. Other probes used were speci¢c for MT-1 and MT-2 mRNA
(supplied by Dr P. Searle, Birmingham University) [11], actin mRNA
[12] and 15 S rRNA (from Dr E. Murray, Roche Products, Welwyn
Garden City). MT-l and MT-2 probes were previously shown to bind
unique sequences [11] and this was con¢rmed here, since each bound
to a single band, the size of which di¡ered slightly on a Northern blot,
and they did not compete for binding (not shown).
2.2. Cytokines
Human recombinant IL-1K and IL-1L were provided by Dr D.
Westemacott, Roche Products, Welwyn Garden City. Human re-
combinant IL-6 was supplied by Prof. L. Aarden, The Netherlands.
2.3. Cell culture
HepG2 cells [13] were cultured in 60 mm2 tissue culture plates
(NUNC) containing RPMI medium (Gibco BRL) supplemented
with 10% heat-inactivated fetal calf serum, 1 mM sodium pyruvate,
1.6 mM glutamine, 100 U/ml penicillin and 100 Wg/ml streptomycin
(37‡C in 5% CO2/air). 1U106 cells were seeded per plate, allowed to
recover for 24 h and stimulated with IL-1K (1000 U/ml), IL-1L
(1000 U/ml), IL-6 (100 U/ml) or Cu (50 WM) for various times before
the monolayer of cells was rinsed twice with 5 ml phosphate-bu¡ered
saline (PBS) and were recovered in 1 ml PBS by scraping. The cells
were centrifuged at 2800Ug at 20‡C and the cell pellet was frozen at
370‡C.
2.4. mRNA extraction
mRNA was extracted essentially as described by Chomczynski and
Sacchi [14]. The resulting RNA pellet was dried brie£y after washing
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in 70% ethanol, re-suspended in 20 Wl 0.5% SDS by heating to 65‡C
for 20 min and frozen at 370‡C until use. Quantitation was per-
formed by spectrophotometry.
2.5. Slot-blot analysis
20 Wg (approximately 5 Wl) total RNA was added to 95 Wl DEPC-
treated water using a 96 well plate (NUNC). An equal volume of ice
cold 20 mM NaOH, 2 mM EDTA was added to denature the RNA.
The RNA was then allowed to drain onto a nylon membrane (Bio-
Rad) by gravity using a Bio-Rad slot-blot apparatus before being
washed with 400 Wl 10 mM NaOH, 1 mM EDTA by vacuum. The
¢lter was then baked at 80‡C for 1 h.
Probes were labelled with 32P using an oligo-labelling kit (Amer-
sham/Pharmacia) (CP, MT-1, MT-2 and actin cDNA) or end-labelled
(rRNA oligonucleotide) using T4 kinase (Life Technologies) as rec-
ommended by the manufacturers. Pre-hybridization, hybridization
and stringency washes were performed using a hybridization oven
(Hybaid), as recommended by the manufacturers. Pre-hybridization
(3 h) and hybridization (18 h) were carried out in 7% SDS, 1 mM
EDTA and 10 mM sodium phosphate bu¡er (pH 7.3) at a temper-
ature which was dependent on the probe being used (CP, actin, MT-1
and MT-2 at 62‡C; rRNA at 60‡C). Filters hybridized with the
cDNAs were washed in 5% SDS, 1 mM EDTA and 10 mM sodium
phosphate bu¡er (pH 7.3) for 60 min at 62‡C, then, a further 30 min
at 62‡C with fresh bu¡er, followed by two more washes each with 1%
SDS, 1 mM EDTA and 10 mM sodium phosphate bu¡er (pH 7.3) at
62‡C for 30 min. When probed with rRNA, the ¢lter was rinsed
brie£y in the 5% SDS wash bu¡er described above at 60‡C, followed
by fresh 5% SDS bu¡er for 3 min at 60‡C. The ¢lters were covered in
cling-wrap and autoradiographed (Fuji X-ray ¢lm) at 370‡C with
intensifying screens (GRI). Quanti¢cation was performed using a
LKB Ultroscan Laser Densitometer (absorbance units per mm2)
and the intensity of the bands was normalized to the control rRNA
level after re-probing. All experiments were repeated on at least three
occasions.
3. Results
3.1. IL-1K and IL-1L up-regulate MT-1 and MT-2 mRNA
expression
When HepG2 cells were stimulated with IL-1K, an increase
in MT-1 and MT-2 mRNA expression was observed. A 3-fold
increase in MT-1 mRNA levels at 8^12 h post-stimulation
with IL-1K was seen which was in contrast to the slightly
decreased expression seen at those times in the unstimulated
cells (Fig. 1A). A second peak (2.8-fold increase) was observed
20^24 h post-stimulation, which coincided with a 1.5-fold in-
duction in MT-1 mRNA in the control cells. Similar results
were seen with MT-2 mRNA expression, with a 4-fold peak
induction at 8^12 h and a similar rise at 20^24 h post-stim-
ulation with IL-1K (Fig. 1B).
IL-1L also induced the expression of MT-1 and MT-2
mRNA in the HepG2 cells with a 5-fold increase in MT-1
mRNA levels at 12^16 h post-stimulation with IL-1L (Fig.
1C). A second smaller peak of induction (2-fold) was seen
at 48 h post-stimulation, while unstimulated cells produced
a 2.4-fold peak induction of MT-1 at 24 h. MT-2 mRNA
showed the greatest response with expression reaching a
peak 19.3-fold increased at 8^16 h post-stimulation with IL-
1L (Fig. 1D), compared to levels of 2.9-fold in the unstimu-
lated control cells. Another smaller rise was observed 48 h
post-stimulation which did not coincide with the small in-
crease in MT-2 mRNA expression in the unstimulated cells.
No signi¢cant changes in actin mRNA in response to cyto-
kines were observed (data not shown).
3.2. IL-6 has a small e¡ect on MT mRNA expression
IL-6 had a lesser stimulatory e¡ect on MT-1 or MT-2
mRNA expression than either form of IL-1. A small transient
increase in MT-1 mRNA (2.7-fold) was observed 4^8 h post-
stimulation with IL-6 compared to a small decrease in MT-1
mRNA levels seen at these times in the unstimulated cells
(Fig. 2A). The cytokine also produced a small increase in
MT-2 mRNA expression (2.8-fold) at 4^8 h (Fig. 2B).
3.3. IL-1K and IL-1L up-regulate CP mRNA expression
When HepG2 cells were stimulated with IL-1K, a 6.5-fold
induction of CP mRNA levels was observed (Fig. 3A). A
second peak (6.4-fold) was seen at 20^24 h, which coincided
with a 1.5-fold increase in CP mRNA levels in the control
cells. IL-1L also produced an increase in CP mRNA expres-
sion (Fig. 3B) with a 3.7-fold induction at 12^16 h post-acti-
vation, compared to a 1.2-fold increase in unstimulated con-
trols at this time. In contrast, only a very small increase in CP
mRNA levels (1.7-fold) was observed, which occurred 4^8 h
after stimulation with IL-6 (Fig. 3C).
Fig. 1. E¡ects of IL-1K and IL-1L on MT-1 and MT-2 mRNA in HepG2 cells. HepG2 cells (1U106 cells) were stimulated with either IL-1K
(1000 U/ml) or IL-1L (1000 U/ml), harvested and mRNA slot-blotted and probed with 32P-labelled cDNA probes for MT-1 and MT-2. Actin
was used as a control probe which showed no signi¢cant changes over the time of the experiment. After autoradiography, bands were quanti-
tated by densitometry and normalized to the intensity of the rRNA probe with the same blots. A and C: MT-1. B and D: MT-2. No IL-1
(E), IL-1K (a), IL-1L (b).
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3.4. Copper increases MT-1, MT-2 and CP mRNA expression
Upon stimulation of HepG2 cells with Cu ions, a substan-
tial increase in MT-1 (16-fold) and MT-2 (10-fold) mRNA
levels was observed (Fig. 4A and B, respectively). This induc-
tion was observed 4^12 h post-induction. Copper also pro-
duced an increase in CP mRNA levels (5.8-fold) which coin-
cided with the peak in MT mRNA (Fig. 4C). A smaller
second peak was seen from about 24 h with all three mRNAs.
4. Discussion
The control of APP synthesis is achieved largely through
cytokine-induced alterations in mRNA expression of the APP
genes in the liver. Although Karin [15] demonstrated that only
MT-2 mRNA expression (not MT-1) was induced by IL-1 in
HepG2 cells. The results presented here are in agreement with
others who have shown that IL-l is capable of inducing MT-1,
MT-2 and CP expression [16].
Here, we have shown that MT genes showed di¡erential
stimulation by IL-1K and IL-1L with the induction by IL-1K
and IL-1L being greater for MT-2 (4- and 19-fold, respec-
tively) (Fig. 1C and D) than MT-1 (3- and 5-fold, respectively
(Fig. 1A and B). In addition, IL-1L was a better inducer of
MT mRNA levels than IL-1K. In general, therefore, MT-2
was the more responsive gene and IL-1L the better stimulator
of the two species.
Although the sequences of IL-1K and IL-1L are dissimilar
[17] and they have both been found to bind the same receptor
with di¡erent a⁄nities (the binding a⁄nity of IL-1K is less
than that for IL-1L) [18], little information is available on
di¡erential actions of the two forms of IL-1 in signal trans-
duction or APP synthesis.
The temporal and quantitative di¡erences in induction of
MT-1, MT-2 and CP mRNA expression could be due to a
di¡erence in the processing of the IL-1K/IL-1R and IL-1L/IL-
1R complexes after internalization by the HepG2 cells and/or
by di¡erent signal transduction mechanisms [19]. Di¡erences
Fig. 2. E¡ects of IL-6 on MT-1 and MT-2 mRNA in HepG2 cells.
As for Fig. 1, but cells were incubated with IL-6 (100 U/ml) A:
MT-1. B: MT-2. No cytokine (E), +IL-6 (a).
Fig. 3. E¡ects of IL-1 and IL-6 on CP mRNA in HepG2 cells.
HepG2 cells were incubated with IL-1K (1000 U/ml), IL-1L (1000
U/ml), IL-6 (100 U/ml) and then probed using a CP cDNA. A: IL-
1K. B: IL-1L. C: IL-6. Open symbols without cytokine, closed sym-
bols with cytokine.
Fig. 4. E¡ects of Cu on MT-1, MT-2 and CP mRNA in HepG2
cells. HepG2 cells were incubated with Cu (50 WM), harvested and
mRNA slot-blotted and probed with 32P-labelled cDNA probes for
MT-1, MT-2 and CP. A: MT-1. B: MT-2. C: CP. Open symbols
without Cu, closed symbols with Cu.
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in processing or receptor recycling could also explain the sec-
ond peak of mRNA expression. Upon binding of IL-1 to its
cell surface receptors, internalization has been found to occur
in a number of cell lines [20]. However, the fate of the IL-1R
after internalization is dependent on the cell type. In ¢bro-
blasts, a continuous level of IL-1R on the cell surface and
recycling of internalized receptors [21] has been noted, while
in T- and B-cells, there is a reduction of receptors on the
plasma membrane (75^80% remaining) [22], with no recycling
of the protein [20]. The double peak in mRNA could therefore
be explained by retro-endocytosis of the complex as can occur
with, for instance, the transferrin receptor [23].
However, two forms of IL-1R have been shown to exist and
to be expressed in a cell speci¢c manner [22,24]. If both forms
are expressed by HepG2 cells, then, complex responses to IL-1
would be expected. IL-1K has been found to migrate to the
nucleus in B- and T-cells in the form of IL-1K/IL-1R com-
plexes [20], implying a nuclear role for IL-lK in signal trans-
duction. A mechanism similar to glucocorticoid signal trans-
duction may be involved: the glucocorticoid receptor plus
ligand migrates to the nucleus, binds to DNA and so modu-
lates gene transcription on its own or in conjunction with
other transcription factors [25]. No evidence for the migration
of IL-1L/IL-1R complexes into the nucleus has been reported
and this may explain the di¡erences seen between the actions
of IL-1K and IL-1L.
Since the second peak produced by IL-1K coincided with
the peak mRNA expression in the unstimulated cells, it may
represent an ampli¢cation of the normal up-regulation of MT
that is seen during cell division. The HepG2 cells that were
used here are adherent cells which were seeded from con£uent
£asks and are so likely to have been at least partially
synchronized in the cell cycle and could so produce a simul-
taneous rise in the MT just prior to cell division as seen for
other cells [26]. MT is an important housekeeping gene and
induction of growth in rat hepatocytes has been shown to
induce high levels of mRNA which were maximal at 48 h.
It was also shown that the e¡ects of growth and metals
were additive which would support the observations that we
have made here [27].
In contrast to IL-1, IL-6 was found to stimulate MT-1 and
MT-2 mRNA levels (Fig. 2), but to have little e¡ect on CP
mRNA (Fig. 3). The increase in CP, MT-1 and MT-2 mRNA
levels induced by IL-6 was observed at 4^8 h post-stimulation,
which is earlier than the stimulatory e¡ects of IL-1. Peak
increases of MT-1 and MT-2 mRNA expression were 2.7-
and 2.8-fold, respectively, while the induction of CP mRNA
was only 1.7-fold. These are compared to the slight reduction
of mRNA levels in the unstimulated cells at 8 h. These results
agree with reports that IL-6 is capable of increasing the
mRNA expression of MT-1 and MT-2 genes, although this
e¡ect was only reported to occur in the presence of dexa-
methasone [28,29]. The same study indicated that IL-1 had
little e¡ect on MT mRNA levels, which is in contrast to the
present ¢nding that IL-1 stimulates MT expression to a
greater extent than IL-6 and to other reports of IL-1 stimu-
lation of MT mRNA expression [15]. Up to 1000 U/ml IL-1
were used by Schroeder and Cousins [28] with no e¡ect, while
the increase in MT mRNA levels was demonstrated here with
100 U/ml (in both cases, U = lymphocyte activating factor
units). The explanation for this di¡erence is not obvious,
but it may be a species di¡erence, since both we and Karin
[15] investigated human cells while Schroeder and Cousins
used rat liver cells.
IL-1K was also the strongest inducer of CP mRNA, which
occurred with similar kinetics to the MT. The second peak
with IL-1K was seen as with MT. Since CP is unlikely to be a
housekeeping gene in HepG2 cells, this suggests that there
may be two cycles of IL-1K response. Again, IL-1L gave a
monophasic response and since MT-1 was similarly up-regu-
lated in these cells, this suggests that the biphasic response
induced by IL-1K is a speci¢c e¡ect of this cytokine. IL-6
has been shown to increase the level of synthesis of CP protein
[30] and it has been reported that IL-6 is an equal good in-
ducer of CP expression as IL-1 [31]. The results obtained here
indicate that any e¡ect of IL-6 on CP is likely to occur at a
post-transcriptional level, rather than transcriptionally, since
we saw little e¡ect of IL-6 on CP mRNA levels.
We also saw a signi¢cant e¡ect of copper on CP mRNA.
Previous reports on the role of metals in CP synthesis have
observed little e¡ect either in vivo [3,4] or in vitro in LEC-rat
liver-derived cell lines [32] with apo-CP being produced even
in the absence of copper. However, neither of these studies
directly investigated the e¡ects on CP mRNA. The CP gene
contains a few super¢cially characterized control elements in-
cluding a C/EBP consensus sequence [33] and one partially
homologous to the rat albumin D site [34], although none
through which a metal response might be controlled. How-
ever, our previous work might explain the mechanism in-
volved. We showed that CAT constructs under the control
of a promoter containing an AP-1 consensus sequence could
be up-regulated by metals, whereas a construct containing an
NFUB element was not [35]. Examination of the rat CP gene
5P region [34] contains no obvious AP-1-binding site (unpub-
lished observation). This suggests that the metal responses in
the CP mRNA level we have seen probably arise due to in-
duction of some other protein dependent either on a unique
metal response element or on AP-1 which in turn enhances the
transcription of the CP mRNA or its stabilization. The char-
acterization of such a factor(s) awaits further work.
In summary, there is a complex interplay between copper
and cytokines in the control of mRNA for MT and CP in
liver cells. Other factors are also involved but the concomitant
up-regulation of these copper-binding proteins may be impor-
tant in their regulation and function during the in£ammatory
response.
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